RAE1 and hepatocellular carcinoma: However, the rate of RAE1 genetic alterations was only about 1.1% and the genetic alterations were not significantly associated with poor OS and DFS in HCC patients, although genetic mutations were closely associated with malignant tumors and a poor prognosis.